A series of substituted imidazo [1, 2-a] pyrazin-8-amines were discovered as novel breast tumor kinase (Brk)/protein tyrosine kinase 6 (PTK6) inhibitors. Tool compounds with low- nanomolar Brk inhibition activity, high selectivity towards other kinases and desirable DMPK properties were achieved to enable the exploration of Brk as an oncology target.
[Voss, Matthew E.; Rainka, Matthew P.; Fleming, Mike; Peterson, Lisa H.; Belanger, David B.; Siddiqui, M. Arshad; Hruza, Alan; Voigt, Johannes; Gray, Kimberly; Basso, Andrea D. Bioorganic and Medicinal Chemistry Letters, 2012 , vol. 22, # 10 p. 3544 - 3549]